I think Novo Nordisk's prediction of a sharp revenue drop is kinda worrying, you know? 🤔 I mean, the Trump administration's price cuts have really hurt their bottom line, and with patent expirations adding to the competition, it's gonna be tough for them to bounce back. But, on the other hand...